Xi'an researchers develop AI framework for diagnosing leukemia
A team of researchers from Xi'an, Shaanxi province, has outlined a new AI framework capable of diagnosing leukemia with 96.5 percent accuracy while protecting patient privacy.
The study, led by Liu Huasheng from the First Affiliated Hospital of Xi'an Jiaotong University, was recently published in the renowned medical journal JAMA Oncology.
Acute Myeloid Leukemia is a notoriously difficult blood cancer to treat. Because the disease varies significantly from person to person due to complex genetic changes, doctors have long struggled to create personalized treatment plans for every patient, according to the research.
The Chinese team found that, by using advanced machine learning, they could combine clinical records, genetic data, and cell images to predict patient outcomes more accurately than when using traditional methods.
- Seven dead, 12 hurt as vehicle rolls over in Yunnan
- Purple sea of?catnip flowers?blooms in Shandong town
- 'Blue tears' turn Fuzhou's beaches fluorescent
- China-made marine-derived antitumor drug to begin combination therapy trials soon
- Wild apple trees create a poetic spring landscape in Xinjiang
- Tianjin town plays leading role in global instrument trade
































